It is noteworthy, however, that enhanced expression of MxA and MHC-I by siRNA treatment does not occur in established human hepatoma cell lines that contain replicating HBV (Meng and Lu, unpublished results), possibly because of defective IFN-β signaling pathways in these hepatoma cells [16]. This evidence concerns the gene MX1 and hepatocellular carcinoma.